Glycoprotein Synthesis Reveals Function of HMGB1 N-glycosylation
June 28th, 2026
Zhong Z, Zhou H, Huang Z, Zhang Y, Wang J, Liu H, Li X. Revealing the Biological Effect of the N-glycosylation of High-Mobility Group Box 1 (HMGB1) Facilitated by Chemical Protein Synthesis. J Am…
SULF2 in Obesity-driven Breast Cancer
June 28th, 2026
Hladik C, Sekhri M, Cen HH, Elayapillai SP, Lee S, Gao B, Dooley W, Milligan T, Hill H, Filatenkov A, Wellberg EA, Hannafon BN. Spatially Resolved Obesity-Driven Molecular Changes in Early Breast…
SULF1 and SUMFs Control the Timing of Zebrafish Morphogenesis
June 28th, 2026
Cervino AS, Basu A, Weiss RJ, Kaur Bajwa G, Marín-Juez R, Grimm SL, Coarfa C, Williams MK. Sulfatase modifying factors control the timing of zebrafish convergence and extension morphogenesis. Nat…
SULF1+ CAFs Drive EMT and Immune Suppression in Colorectal Cancer
June 28th, 2026
Wang J, He Q, Hu J, Gao L, Sheng N, Zhou S, Gong J, Gu Y, Chen H, Xu Y, Yan T, Wang Z. A multi-omics dissection of INHBA+ CAF-mediated epithelial-mesenchymal transition and immune suppression in…
JOSD1-stabilized SULF1 Promotes Gastric Cancer
June 28th, 2026
Liu L, Ma Z, Zhang Y, Ye Z, Li H, Shi W, Jiao Z. JOSD1 stabilizes SULF1 to activate Wnt7B-FZD1 signaling in gastric cancer. Transl Oncol. 2026 Jul;69:102813. doi: 10.1016/j.tranon.2026.102813. Epub…
Human SULFs Regulate Growth Factor-Heparan Sulfate Interactions
June 28th, 2026
Timm BM, Follmar JL, Porell RN, Vallet SD, Glass K, Thacker BE, Glass CA, Gordts P, Vivès RR, Godula K. Human Sulfatases Use Dual Mechanisms to Control Growth Factor-Heparan Sulfate Interactions.…
SULF1 drives Endothelial-Mesenchymal Transition in Atherosclerosis
June 28th, 2026
Guo Z, Zhang W, Shu X, Xu H, Zhou K, Gao H, Guo B, Fan L, Yang X. Histone H3 lysine 18 lactylation-mediated SULF1 transcription promotes atherosclerosis by regulating endothelial-to-mesenchymal…
SULF2/TIMP3 axis connects hepatic fibrosis to HCC
March 14th, 2026
Zhang S, Sun P, Zhang J, Li X. Cross-organ single-cell integration identifies liver-specific fibroblast programs and HGF-MET/AGT-AGTR1B axes that link fibrosis to hepatocarcinogenesis. Neuro…
SULF1 drives TME remodeling in PDAC
March 14th, 2026
Xu J, Qian K, Ding Y, Cheng J, Zhang X, Huang Y, Liu B. Multi-Omic and Spatial Profiling Identifies an Epithelial DKK1 Associated with Microenvironmental Remodeling in Pancreatic Ductal…
Function of the SULF hydrophilic domain
March 14th, 2026
Demongin C, Tao J, El Omrani N, Uchimura K, Basdevant N, Daniel R. The hydrophilic domain of HSulf Endosulfatases: an intrinsically disordered region governing enzyme functions and therapeutic…
Congrats to Pritha on her paper on SULF1+CAF in HNSCC
March 14th, 2026
Mukherjee P, Benicky J, Panigrahi A, Ailles L, Goldman R. SULF1 in Cancer Associated Fibroblasts Promotes Invasion in Head and Neck Cancer Cell Lines. Cancer Med. 2026 Jan;15(1):e71540. doi:…
Updated findings on the inhibition of SULF enzymes by a fucosylated GAG isolated from a sea cucumber.
January 10th, 2026
Farrag M, Aljuhani R, Benicky J, Al Ahmed H, Misra SK, Mishra SK, Sharp JS, Doerksen RJ, Goldman R, Pomin VH. Heparan-6-O-endosulfatase 2, a cancer-related proteoglycan enzyme, is effectively…
Reem Aljuhani published our results on the production and inhibition of SULF1
January 10th, 2026
Aljuhani R, Benicky J, Panigrahi A, Mukherjee P, Sanda M, Zhu S, Nováková Z, Pomin VH, Liu J, Davidson B, Bařinka C, Goldman R. Production and inhibition of human Heparan 6-O-Endosulfatase SULF1.…
SULF1 in endothelial senescence and atherosclerosis
January 10th, 2026
Jiang MT, Wan SL, Shen XY, Zhang ZB, He ZQ, Hu YX, Liang C. SULF1’s Role in Endothelial Senescence and Atherosclerosis: Insights from Single-Cell and Bulk Transcriptomics. J Inflamm Res. 2025 Dec…
SULF1 in reward and aversion learning
January 10th, 2026
Miya K, Ohta K, Keino-Masu K, Okada T, Mizuno S, Takahashi S, Macpherson T, Hikida T, Masu M. Essential Roles of Heparan Sulfate Endosulfatase Sulf1 in Reward and Aversion Learning Through Distinct…
SULF2 inhibition sensitizes TNBC to paclitaxel
January 10th, 2026
Manouchehri JM, Datta J, Marcho LM, Stover D, Ganju RK, Ramaswamy B, Carson WE, Mittra A, Zhang X, Schnell PM, Yue Y, Rubinstein MP, Cherian MA. Sulfatase 2 inhibition sensitizes triple-negative…
Our study of SARS-CoV-2 glycosylation reached 226 citations
January 10th, 2026
Sanda M, Morrison L, Goldman R. (2021) N- and O-glycosylation of the SARS-CoV-2 spike protein. Anal Chem. 2021 Feb 2;93(4):2003-2009. PMID:…
Aspirin reduces SARS-CoV-2 binding to ACE2 via altered glycosylation of the spike protein
January 10th, 2026
Perico L, Bovio A, Tomasoni S, Trionfini P, Cerullo D, Corna D, Pezzotta A, Locatelli M, Alberti M, Benigni A, Remuzzi G. Acetylsalicylic acid disrupts SARS-CoV-2 spike protein glycosylation and…
SULF1 promotes colon cancer metastasis and treatment resistance
January 10th, 2026
Li H, Xie Y. MARCHF1-mediated SULF1 degradation blocks THBS2/TGF-β/SMAD2/3 signaling to reverse colon cancer metastasis and 5-FU resistance. iScience Volume 29, Issue 1114476 January 16,…
Real-time proteomics in oncology tumor boards
January 9th, 2026
Hunt AL, Randall J, Mansukhani MM, Nyberg K, Nutcharoen A, Davis J, Corgiat B, Mueller C, Melvin S, Sharma M, Johnston L, Swain W, Abulez T, Bateman NW, Maxwell GL, Deeken J, Benyounes A, Petricoin…
Histology-resolved proteomics in prostate cancer
January 9th, 2026
Hunt AL, Barakat W, Makohon-Moore SC, Hood BL, Conrads KA, Wilson KN, Abulez T, Ogata J, Pienta KJ, Lotan TL, Mani H, Trump DL, Bateman NW, Conrads TP. Histology-resolved proteomics reveals distinct…
Our review of heparan sulfatase mechanism of action and inhibition
January 9th, 2026
Mayieka M, Benicky J, Goldman R, Huang X. Sulfatases: Catalytic Mechanism, Substrate Preferences, and Carbohydrate-Based Inhibitor Design. Israel Journal of Chemistry. 2025 Dec 20. doi:…
Gregory Furletti will present our study of SULF1 in HNSCC at the USCAP in San Antonio
January 9th, 2026
Furletti G, Llaguno Guerrero TJ, Schrom EC, Goldman R, Davidson B, Kallakury B. Spatial Patterning Analysis of SULF1 Expression at Tumor–Stroma Interfaces in Head and Neck Squamous Cell Carcinoma:…
Congrats to Pritha on a SULF1 paper accepted in Cancer Medicine
January 9th, 2026
Mukherjee P, Benicky J, Panigrahi A, Ailles L, Goldman R. SULF1 in cancer associated fibroblasts promotes invasion in head and neck cancer cell lines. Cancer Medicine, in…
Reem Aljuhani presents a poster on SULF1 structure-activity at the NIH-FDA Glycoscience Research Day
June 11th, 2025
Aljuhani, R., Benicky, J., Panigrahi, A., Mukherjee, P., Nováková, Z., Bařinka, C., Liu, J., Goldman, R. Purification and in vitro Characterization of Human Extracellular Heparan…
Dr. Panigrahi shows that Galectin-3-Binding Proptein is a specific and selective inhibitor of Sulf-2
June 11th, 2025
Galectin-3-Binding Protein Inhibits Extracellular Heparan 6-O-Endosulfatase Sulf-2. Panigrahi A, Benicky J, Aljuhani R, Mukherjee P, Nováková Z, Bařinka C, Goldman R. Mol Cell Proteomics. 2024…
Amy Lum is selected to present at the Laidlaw Conference at Columbia University
June 11th, 2025
Amy Lum, Julius Benicky, Radoslav Goldman. Generation of Galectin-3-Binding Protein (LG3BP) F357W Mutant as a Crucial Resource for Characterization of Sulf-2/LG3BP…
SULF1+ CAF support progression of colorectal cancer
June 11th, 2025
Cancer-Associated Fibroblasts Expressing Sulfatase 1 Facilitate VEGFA-Dependent Microenvironmental Remodeling to Support Colorectal Cancer. Wang H, Chen J, Chen X, Liu Y, Wang J, Meng Q, Wang H, He…
SULFs regulate bone marrow hematopoiesis
June 11th, 2025
Myeloid deficiency of heparan sulfate 6-O-endosulfatases impairs bone marrow hematopoiesis. Whitehead AK, Wang Z, Boustany RJ, Vivès RR, Lazartigues E, Liu J, Siggins RW, Yue X. Matrix Biol. 2024…
A nice paper showing how PDX engraftment predict survival of OSCC patients
June 11th, 2025
Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes. Waas M, Karamboulas C, Wu BZ, Khan S, Poon S, Meens J, Govindarajan M, Khoo A, Mejia-Guerrero…
Our collaboration with Glycan Therapeutics on MS quantification of SULF activity is selected a Glycobiology Editor’s Choice publication
June 11th, 2025
Development of a method to measure the activity of heparan sulfate 6-endosulfatase for biological research. Wang Z, Benicky J, Mukherjee P, Laing J, Xu Y, Pagadala V, Wu S, Hippensteel JA, Goldman…
Dr. Panigrahi et al. describe an LCM-LC-MS/MS method for spatially resolved proteomics of archived FFPE tissues of OSCC patients
June 11th, 2025
dia-PASEF Proteomics of Tumor and Stroma LMD Enriched from Archived HNSCC Samples. Panigrahi A, Hunt AL, Assis D, Willetts M, Kallakury BV, Davidson B, Ahn J, Conrads TP, Goldman R. ACS Omega. 2025…
Our collaboration with Dr. Pomin et al. shows how glycan polymers inhibit Sulf-2 activity
June 11th, 2025
Heparan-6-O-endosulfatase 2, a cancer-related proteoglycan enzyme, is effectively inhibited by a specific sea cucumber fucosylated glycosaminoglycan. Farrag M, Aljuhani R, Benicky J, Al Ahmed H,…
Congrats to Dr. Mukherjee on a study showing SULF2-mediated invasion of HNSCC cells co-cultured with primary CAF
June 11th, 2025
Heparan-6-O-Endosulfatase 2 Promotes Invasiveness of Head and Neck Squamous Carcinoma Cell Lines in Co-Cultures with Cancer-Associated Fibroblasts. Mukherjee P, Zhou X, Benicky J, Panigrahi A,…
Our collaborative paper with Glycan Therapeutics on MS analysis of SULF activity is a Glycobiology Editor’s Choice
June 11th, 2025
Development of a method to measure the activity of heparan sulfate 6-endosulfatase for biological research. Wang Z, Benicky J, Mukherjee P, Laing J, Xu Y, Pagadala V, Wu S, Hippensteel JA, Goldman…
Our collaboration with colleagues at the University of Mississippi reveals how glycan polymers inhibit Sulf-2 activity
June 11th, 2025
Galectin-3-binding protein inhibits extracellular heparan 6-O-endosulfatse Sulf-2. Panigrahi A, Benicky J, Aljuhani R, Mukherjee P, Nováková Z, Bařinka C, Goldman R. bioRxiv. 2023 Dec…
Congrats to Dr. Panigrahi & colleagues on a spatially resolved proteomics study of FFPE tissues of HNSCC patients
June 11th, 2025
dia-PASEF Proteomics of Tumor and Stroma LMD Enriched from Archived HNSCC Samples. Panigrahi A, Hunt AL, Assis D, Willetts M, Kallakury BV, Davidson B, Ahn J, Conrads TP, Goldman R. ACS Omega. 2025…
SULFs in cancer metastasis
June 25th, 2024
6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets. Han M, Zhu H, Chen X, Luo X. Am J Cancer Res. 2024 Feb 25;14(2):897-916. doi:…
Glycoproteins and cancer-stromal cell interactions mediate resistance to HER2-targeting therapies
June 25th, 2024
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies. Goyette MA, Stevens LE, DePinho CR, Seehawer M, Nishida J, Li Z,…
Mucin-selective proteolytic degradation
June 25th, 2024
Design of a mucin-selective protease for targeted degradation of cancer-associated mucins. Pedram K, Shon DJ, Tender GS, Mantuano NR, Northey JJ, Metcalf KJ, Wisnovsky SP, Riley NM, Forcina GC,…
A review of glycosaminoglycan biology
June 25th, 2024
A biological guide to glycosaminoglycans: current perspectives and pending questions. Ricard-Blum S, Vivès RR, Schaefer L, Götte M, Merline R, Passi A, Heldin P, Magalhães A, Reis CA, Skandalis…
Congrats to Dr. Pritha Mukherjee on a paper on inhibitors of HNSCC cell invasion
June 25th, 2024
Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models. Mukherjee P, Zhou X, Galli S, Davidson B, Zhang L, Ahn J, Aljuhani…
Congrats to Amy Lum
June 25th, 2024
Congrats to Amy Lum, undergraduate student researcher, on receipt of a Laidlaw scholarship supporting her research at the…
A novel way to model protein-carbohydrate interactions
June 25th, 2024
Highly accurate carbohydrate-binding site prediction with DeepGlycanSite. Xinheng He, Lifen Zhao, Yinping Tian, Rui Li, Qinyu Chu, Zhiyong Gu, Mingyue Zheng, Yusong Wang, Shaoning Li, Hualiang…
Congrats to Dr. Aswini Panigrahi on a paper showing SULF2 inhibition by galectin-3-binding protein
June 25th, 2024
Galectin-3-binding protein inhibits extracellular heparan 6-O-endosulfatase Sulf-2. Panigrahi A, Benicky J, Aljuhani R, Mukherjee P, Nováková Z, Bařinka C, Goldman R. Mol Cell Proteomics. 2024…
Our proteomics study of OSCC survival will be presented at the 2024 ASMS meeting in Anaheim
February 18th, 2024
A study of LCM microdissected tumors analyzing proteins in tumor epithelial and stroma fractions associated with node positivity and poor survival of HNSCC patients. DIA-PASEF proteomic analysis of…
Our paper on the regulation of SULF2 activity by galectin3 binding protein is now under review
February 12th, 2024
Galectin-3-binding protein inhibits extracellular heparan 6-O-endosulfatse Sulf-2. Panigrahi A, Benicky J, Aljuhani R, Mukherjee P, Nováková Z, Bařinka C, Goldman R. bioRxiv. 2023 Dec…
